The Food and Drug Administration inspected Endometriosis & Reproductive Surgery Specialists, P.L.L.C. in Scottsdale on April 21, focusing on human cellular, tissue, and gene therapies, according to data posted on the FDA’s website.
The final report stated that Endometriosis & Reproductive Surgery Specialists, P.L.L.C. was not required to take corrective measures regarding the organization’s management practices.
The FDA conducts routine inspections at facilities nationwide to assess whether workplaces and their products comply with laws and regulations intended to enhance public health. Results from these inspections are released to the public.
According to its website, the FDA is a federal agency tasked with overseeing the production and distribution of human and animal drugs, biological products, medical supplies and tobacco items to ensure their safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
